Skip to content

Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder Mistreatment

Mentalizing Imagery Therapy for Caregivers to Address Risk of Elder Mistreatment (MIT-CARE)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07648238
Acronym
(MIT-CARE)
Enrollment
50
Registered
2026-06-15
Start date
2026-08-01
Completion date
2028-06-30
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Health

Keywords

Mentalizing Imagery Therapy, Mindfulness Exercises, dementia family caregiver

Brief summary

The purpose of this study is to establish the clinical efficacy of Mentalizing Imagery Therapy (MIT) for Alzheimer's Disease and Related Disorders (ADRD) family caregivers in terms of mentalizing and elder mistreatment (EM) risk factors of stress, depression, and suicidality and to identify the mechanistic impacts of MIT on ADRD family caregivers' mental health,including stress, depression, and suicidality.

Interventions

MIT is a 4-week, app-delivered behavioral program integrating guided imagery, mindfulness, and perspective-taking practices designed to enhance mentalizing, emotion regulation, and self compassion. MIT is reinforced by weekly 90-minute virtual group sessions

BEHAVIORALMindfulness Exercises.

Mindfulness exercises (ME) is a 4-week, app-delivered program featuring daily self-guided mindfulness practices and reflective exercises aimed at reducing depression and stress.ME is self-guided and does not include group sessions.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER
National Institute on Aging (NIA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Primary family ADRD caregivers * Recruited nationally. * Caring for someone aged 60 or older * Provide at least 8 hours of care weekly * Report at least mild depressive symptoms (PHQ-9 ≥5) * Use a smartphone at least five days per week.

Exclusion criteria

* Active psychosis or mania * A suicide attempt in the last 6 months or current suicidal intent * Self-reported memory or cognitive complaints * Unstable medical conditions or planned major surgery * Moderate to severe substance use disorders.

Design outcomes

Primary

MeasureTime frameDescription
Change in perceived stress as measured by self-reported daily stressFrom Baseline through Week 10This is scored on a scale from 0-10, with 0 indicating no stress, and 10 indicating the day was extremely stressful

Secondary

MeasureTime frameDescription
Change in perceived stress as measured by Perceived Stress Scale (PSS)Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10The PSS is a 10-item psychological instrument measuring the degree to which situations in one's life are appraised as stressful. Items are scored from 0-4, with total scores ranging from 0-40. Higher scores indicate greater perceived stress.
Change in depression as measured by Patient Health Questionnaire-9 (PHQ-9)Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10PHQ-9 is a 9-item self-report measure used to assess the severity of depressive symptoms . Each item is scored from 0 ("Not at all") to 3 ("Nearly every day"), resulting in a total score ranging from 0 to 27. Higher scores indicate greater depressive symptom severity.
Depression as measured by self-rated daily depression severityFrom baseline through Week 10this will be reported as the number of times participant felt feel depressed, sad, or hopeless each day
Suicidality as measured by self-reported daily suicidalityFrom baseline through Week 10this will be reported as the number of times participant felt they would be better off dead or thinking about hurting themselves each day
Change in Mentalization as Measured by the Mentalization Questionnaire (MZQ)Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10This is a 15 item questionnaire and each is scored on a 5-point Likert scale for a score range from 15-75. Higher scores often indicate greater mentalizing deficits
Change in Mindfulness as Measured by the Mindfulness Subscale of the Self-Compassion Scale (SCS)Baseline, Week 2, Week 4, Week 6, Week 8, and Week 10The subscale consists of 4 items rated on a 5-point Likert scale ranging from 1 ("Almost Never") to 5 ("Almost Always"). Scores are calculated as the mean of the item responses, with higher scores indicating greater mindfulness.
Change in Self-compassion as measured by the Self-Compassion ScaleBaseline, Week 2, Week 4, Week 6, Week 8, and Week 10This has 26 items rated on a 5-point Likert scale ranging from 1 ("Almost Never") to 5 ("Almost Always"). Scores are calculated by averaging item responses after reverse-scoring negatively worded items. Total scores range from 1 to 5, with higher scores indicating greater self-compassion
Emotion Regulation as measured by self-reported daily emotion regulationFrom baseline through Week 10This will be reported as number of times participant felt angry or anxious and how often they lost control over their behaviors each day

Countries

United States

Contacts

CONTACTWesley Browning, PhD
wesley.r.browning@uth.tmc.edu256.270.5286
CONTACTAsha Jacob
Asha.P.Jacob@uth.tmc.edu(713) 500-2187
PRINCIPAL_INVESTIGATORWesley Browning, PhD

The University of Texas Health Science Center, Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026